Q13586 (STIM1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 130.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Stromal interaction molecule 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 685 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Plays a role in mediating store-operated Ca2+ entry (SOCE), a Ca2+ influx following depletion of intracellular Ca2+ stores. Acts as Ca2+ sensor in the endoplasmic reticulum via its EF-hand domain. Upon Ca2+ depletion, translocates from the endoplasmic reticulum to the plasma membrane where it activates the Ca2+ release-activated Ca2+ (CRAC) channel subunit, TMEM142A/ORAI1. Ref.4 Ref.17 Ref.18 Ref.19 Ref.20 Ref.21 Ref.23 Ref.24 Ref.30 |
| Subunit structure | Forms homooligomers and heterooligomers with STIM2. Interacts with ORAI1. Interacts with MAPRE1; probably required for targeting to the growing microtubule plus ends. Interacts with EFCAB4B/CRACR2A; the interaction is direct and takes place in absence of Ca2+. Forms a complex with EFCAB4B/CRACR2A and ORAI1 at low concentration of Ca2+, the complex dissociates at elevated Ca2+ concentrations. Interacts with TMEM66/SARAF, promoting a slow inactivation of STIM1-dependent SOCE activity, possibly by facilitating the deoligomerization of STIM1. Interacts with ASPH (isoform 8). Ref.6 Ref.7 Ref.15 Ref.25 Ref.26 Ref.29 Ref.30 Ref.31 |
| Subcellular location | Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-pass type I membrane protein. Cytoplasm › cytoskeleton. Note: Translocates from the endoplasmic reticulum to the cell membrane in response to a depletion of intracellular calcium. Associated with the microtubule network at the growing distal tip of microtubules. Ref.5 Ref.17 Ref.19 Ref.26 |
| Tissue specificity | Ubiquitously expressed in various human primary cells and tumor cell lines. Ref.5 Ref.6 |
| Domain | The microtubule tip localization signal (MtLS) motif; mediates interaction with MAPRE1 and targeting to the growing microtubule plus ends. Ref.26 The STIM1 Orai1-activating region/CRAC-activating domain (SOAR/CAD) mediates interaction with ORAI1 to activate the channel. Ref.26 |
| Post-translational modification | Glycosylation is required for cell surface expression. Phosphorylated predominantly on Ser residues. Ref.5 |
| Involvement in disease | Immune dysfunction with T-cell inactivation due to calcium entry defect 2 (IDTICED2) [MIM:612783]: An immune disorder characterized by recurrent infections, impaired T-cell activation and proliferative response, decreased T-cell production of cytokines, lymphadenopathy, and normal lymphocytes counts and serum immunoglobulin levels. Additional features include thrombocytopenia, autoimmune hemolytic anemia, non-progressive myopathy, partial iris hypoplasia, hepatosplenomegaly and defective enamel dentition. |
| Miscellaneous | Transfection of STIM1 into cells derived from a rhabdoid tumor and from a rhabdomyosarcoma that do not express detectable levels of STIM1 can induce cell death, suggesting a possible role in the control of rhabdomyosarcomas and rhabdoid tumors. |
| Sequence similarities | Contains 1 EF-hand domain. Contains 1 SAM (sterile alpha motif) domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| itself | 2 | EBI-448878,EBI-448878 | ||
| CALM | P62157 | 2 | EBI-448878,EBI-397403 | From a different organism. |
| EFCAB4B | Q9BSW2 | 3 | EBI-448878,EBI-739773 | |
| ORAI1 | Q96D31 | 11 | EBI-448878,EBI-2291476 | |
| STIM2 | Q9P246 | 4 | EBI-448878,EBI-448891 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 22 | 22 | Potential | |||||||||||||||||||||||||||||||||||||||
| Chain | 23 – 685 | 663 | Stromal interaction molecule 1 | PRO_0000033326 | ||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 23 – 213 | 191 | Extracellular Potential | |||||||||||||||||||||||||||||||||||||||
| Transmembrane | 214 – 234 | 21 | Helical; Potential | |||||||||||||||||||||||||||||||||||||||
| Topological domain | 235 – 685 | 451 | Cytoplasmic Potential | |||||||||||||||||||||||||||||||||||||||
| Domain | 63 – 98 | 36 | EF-hand | |||||||||||||||||||||||||||||||||||||||
| Domain | 132 – 200 | 69 | SAM | |||||||||||||||||||||||||||||||||||||||
| Calcium binding | 76 – 87 | 12 | Potential | |||||||||||||||||||||||||||||||||||||||
| Region | 334 – 444 | 111 | SOAR/CAD | |||||||||||||||||||||||||||||||||||||||
| Coiled coil | 248 – 442 | 195 | Ref.31 | |||||||||||||||||||||||||||||||||||||||
| Motif | 642 – 645 | 4 | Microtubule tip localization signal | |||||||||||||||||||||||||||||||||||||||
| Compositional bias | 270 – 336 | 67 | Glu-rich | |||||||||||||||||||||||||||||||||||||||
| Compositional bias | 600 – 629 | 30 | Pro/Ser-rich | |||||||||||||||||||||||||||||||||||||||
| Compositional bias | 672 – 685 | 14 | Lys-rich | |||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 257 | 1 | Phosphoserine Ref.9 | |||||||||||||||||||||||||||||||||||||||
| Modified residue | 519 | 1 | Phosphoserine Ref.13 | |||||||||||||||||||||||||||||||||||||||
| Modified residue | 524 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||||
| Modified residue | 575 | 1 | Phosphoserine Ref.10 Ref.12 | |||||||||||||||||||||||||||||||||||||||
| Modified residue | 608 | 1 | Phosphoserine Ref.8 Ref.11 | |||||||||||||||||||||||||||||||||||||||
| Modified residue | 660 | 1 | Phosphoserine Ref.11 Ref.12 | |||||||||||||||||||||||||||||||||||||||
| Modified residue | 665 | 1 | Phosphothreonine Ref.12 | |||||||||||||||||||||||||||||||||||||||
| Modified residue | 668 | 1 | Phosphoserine Ref.11 Ref.12 | |||||||||||||||||||||||||||||||||||||||
| Glycosylation | 131 | 1 | N-linked (GlcNAc...) Ref.7 | |||||||||||||||||||||||||||||||||||||||
| Glycosylation | 171 | 1 | N-linked (GlcNAc...) Ref.7 Ref.16 Ref.22 Ref.27 | |||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 538 | 1 | P → S. Corresponds to variant rs35960304 [ dbSNP | Ensembl ]. | VAR_061878 | ||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 76 | 1 | D → A or N: Increases Ca(2+) influx even when Ca(2+) stores are not depleted. Ref.17 Ref.20 Ref.26 | |||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 78 | 1 | D → N: Increases Ca(2+) influx even when Ca(2+) stores are not depleted. Ref.20 Ref.26 | |||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 87 | 1 | E → A or Q: Increases Ca(2+) influx through activation of CRAC channels, even when Ca(2+) stores are not depleted. Ref.20 Ref.24 Ref.26 | |||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 644 – 645 | 2 | IP → NN: Loss of interaction with MAPRE1 and association with the growing microtubule plus ends. Ref.26 | |||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 556 | 1 | S → R in AAC51627. Ref.1 | |||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||
| Helix | 64 – 73 | 10 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 80 – 83 | 4 | ||||||||||||||||||||||||||||||||||||||||
| Turn | 85 – 90 | 6 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 91 – 95 | 5 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 102 – 108 | 7 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 110 – 112 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 117 – 126 | 10 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 128 – 131 | 4 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 134 – 145 | 12 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 150 – 157 | 8 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 163 – 167 | 5 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 171 – 174 | 4 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 183 – 199 | 17 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 345 – 391 | 47 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 393 – 397 | 5 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 400 – 404 | 5 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 408 – 437 | 30 | ||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning of a novel human gene (D11S4896E) at chromosomal region 11p15.5." Parker N.J., Begley C.G., Smith P.J., Fox R.M. Genomics 37:253-256(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Fetal liver and Placenta. |
| [2] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Pancreas. |
| [4] | "GOK: a gene at 11p15 involved in rhabdomyosarcoma and rhabdoid tumor development." Sabbioni S., Barbanti-Brodano G., Croce C.M., Negrini M. Cancer Res. 57:4493-4497(1997) [PubMed] [Europe PMC] [Abstract] Cited for: POSSIBLE ROLE IN CANCER DEVELOPMENT. |
| [5] | "STIM1: a novel phosphoprotein located at the cell surface." Manji S.S., Parker N.J., Williams R.T., van Stekelenburg L., Pearson R.B., Dziadek M., Smith P.J. Biochim. Biophys. Acta 1481:147-155(2000) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, TISSUE SPECIFICITY, GLYCOSYLATION, PHOSPHORYLATION. |
| [6] | "Identification and characterization of the STIM (stromal interaction molecule) gene family: coding for a novel class of transmembrane proteins." Williams R.T., Manji S.S.M., Parker N.J., Hancock M.S., van Stekelenburg L., Eid J.-P., Senior P.V., Kazenwadel J.S., Shandala T., Saint R., Smith P.J., Dziadek M.A. Biochem. J. 357:673-685(2001) [PubMed] [Europe PMC] [Abstract] Cited for: SUBUNIT, TISSUE SPECIFICITY. |
| [7] | "Stromal interaction molecule 1 (STIM1), a transmembrane protein with growth suppressor activity, contains an extracellular SAM domain modified by N-linked glycosylation." Williams R.T., Senior P.V., van Stekelenburg L., Layton J.E., Smith P.J., Dziadek M.A. Biochim. Biophys. Acta 1596:131-137(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SUBUNIT, GLYCOSYLATION AT ASN-131 AND ASN-171. |
| [8] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-608, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment." Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J. J. Proteome Res. 7:5167-5176(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-257, MASS SPECTROMETRY. Tissue: T-cell. |
| [10] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-575, MASS SPECTROMETRY. Tissue: Platelet. |
| [11] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-608; SER-660 AND SER-668, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-575; SER-660; THR-665 AND SER-668, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [13] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-519, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [15] | "Junctate is a Ca2+-sensing structural component of Orai1 and stromal interaction molecule 1 (STIM1)." Srikanth S., Jew M., Kim K.D., Yee M.K., Abramson J., Gwack Y. Proc. Natl. Acad. Sci. U.S.A. 109:8682-8687(2012) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ASPH. |
| [16] | "Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry." Zhang H., Li X.-J., Martin D.B., Aebersold R. Nat. Biotechnol. 21:660-666(2003) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION AT ASN-171. |
| [17] | "STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx." Liou J., Kim M.L., Heo W.D., Jones J.T., Myers J.W., Ferrell J.E. Jr., Meyer T. Curr. Biol. 15:1235-1241(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF ASP-76. |
| [18] | "STIM1, an essential and conserved component of store-operated Ca2+ channel function." Roos J., DiGregorio P.J., Yeromin A.V., Ohlsen K., Lioudyno M., Zhang S., Safrina O., Kozak J.A., Wagner S.L., Cahalan M.D., Velicelebi G., Stauderman K.A. J. Cell Biol. 169:435-445(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [19] | "STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane." Zhang S.L., Yu Y., Roos J., Kozak J.A., Deerinck T.J., Ellisman M.H., Stauderman K.A., Cahalan M.D. Nature 437:902-905(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [20] | "Large store-operated calcium selective currents due to co-expression of Orai1 or Orai2 with the intracellular calcium sensor, Stim1." Mercer J.C., Dehaven W.I., Smyth J.T., Wedel B., Boyles R.R., Bird G.S., Putney J.W. Jr. J. Biol. Chem. 281:24979-24990(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF ASP-76; ASP-78 AND GLU-87. |
| [21] | "Orai1 and STIM reconstitute store-operated calcium channel function." Soboloff J., Spassova M.A., Tang X.D., Hewavitharana T., Xu W., Gill D.L. J. Biol. Chem. 281:20661-20665(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [22] | "Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach." Lewandrowski U., Moebius J., Walter U., Sickmann A. Mol. Cell. Proteomics 5:226-233(2006) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-171, MASS SPECTROMETRY. Tissue: Platelet. |
| [23] | "Amplification of CRAC current by STIM1 and CRACM1 (Orai1)." Peinelt C., Vig M., Koomoa D.L., Beck A., Nadler M.J.S., Koblan-Huberson M., Lis A., Fleig A., Penner R., Kinet J.-P. Nat. Cell Biol. 8:771-773(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [24] | "STIM1 has a plasma membrane role in the activation of store-operated Ca(2+) channels." Spassova M.A., Soboloff J., He L.-P., Xu W., Dziadek M.A., Gill D.L. Proc. Natl. Acad. Sci. U.S.A. 103:4040-4045(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF GLU-87. |
| [25] | "STIM2 protein mediates distinct store-dependent and store-independent modes of CRAC channel activation." Parvez S., Beck A., Peinelt C., Soboloff J., Lis A., Monteilh-Zoller M., Gill D.L., Fleig A., Penner R. FASEB J. 22:752-761(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ORAI1. |
| [26] | "An EB1-binding motif acts as a microtubule tip localization signal." Honnappa S., Gouveia S.M., Weisbrich A., Damberger F.F., Bhavesh N.S., Jawhari H., Grigoriev I., van Rijssel F.J., Buey R.M., Lawera A., Jelesarov I., Winkler F.K., Wuthrich K., Akhmanova A., Steinmetz M.O. Cell 138:366-376(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH MAPRE1, SUBCELLULAR LOCATION, DOMAIN MICROTUBULE TIP LOCALIZATION SIGNAL, MUTAGENESIS OF 644-ILE-PRO-645. |
| [27] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-171, MASS SPECTROMETRY. Tissue: Liver. |
| [28] | "STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity." Picard C., McCarl C.A., Papolos A., Khalil S., Luthy K., Hivroz C., LeDeist F., Rieux-Laucat F., Rechavi G., Rao A., Fischer A., Feske S. N. Engl. J. Med. 360:1971-1980(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN IDTICED2. |
| [29] | "A novel EF-hand protein, CRACR2A, is a cytosolic Ca2+ sensor that stabilizes CRAC channels in T cells." Srikanth S., Jung H.J., Kim K.D., Souda P., Whitelegge J., Gwack Y. Nat. Cell Biol. 12:436-446(2010) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH EFCAB4B. |
| [30] | "SARAF inactivates the store operated calcium entry machinery to prevent excess calcium refilling." Palty R., Raveh A., Kaminsky I., Meller R., Reuveny E. Cell 149:425-438(2012) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH TMEM66. |
| [31] | "Structural and mechanistic insights into the activation of Stromal interaction molecule 1 (STIM1)." Yang X., Jin H., Cai X., Li S., Shen Y. Proc. Natl. Acad. Sci. U.S.A. 109:5657-5662(2012) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 344-444, COILED-COIL REGION, SUBUNIT. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U52426 mRNA. Translation: AAC51627.1. CH471158 Genomic DNA. Translation: EAX02581.1. BC021300 mRNA. Translation: AAH21300.1. | ||||||||||||||||||
| IPI | IPI00299063. | ||||||||||||||||||
| RefSeq | NP_003147.2. NM_003156.3. | ||||||||||||||||||
| UniGene | Hs.501735. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | Q13586. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| DIP | DIP-31121N. | ||||||||||||||||||
| IntAct | Q13586. 8 interactions. | ||||||||||||||||||
| STRING | 9606.ENSP00000300737. | ||||||||||||||||||
Protein family/group databases | |||||||||||||||||||
| TCDB | 1.A.52.1.1. Ca2+ release-activated Ca2+ (CRAC) channel (CRAC-C) family. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | Q13586. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 209572721. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | Q13586. | ||||||||||||||||||
| PRIDE | Q13586. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| DNASU | 6786. | ||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000300737; ENSP00000300737; ENSG00000167323. | ||||||||||||||||||
| GeneID | 6786. | ||||||||||||||||||
| KEGG | hsa:6786. | ||||||||||||||||||
| UCSC | uc001lyv.2. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 6786. | ||||||||||||||||||
| GeneCards | GC11P003882. | ||||||||||||||||||
| H-InvDB | HIX0009379. | ||||||||||||||||||
| HGNC | HGNC:11386. STIM1. | ||||||||||||||||||
| HPA | HPA011088. HPA012123. | ||||||||||||||||||
| MIM | 605921. gene. 612783. phenotype. | ||||||||||||||||||
| neXtProt | NX_Q13586. | ||||||||||||||||||
| Orphanet | 169090. Severe combined immunodeficiency due to CRAC channel dysfunction. | ||||||||||||||||||
| PharmGKB | PA36195. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | NOG307699. | ||||||||||||||||||
| HOGENOM | HOG000261647. | ||||||||||||||||||
| HOVERGEN | HBG054652. | ||||||||||||||||||
| InParanoid | Q13586. | ||||||||||||||||||
| KO | K16059. | ||||||||||||||||||
| OMA | NIHKQMD. | ||||||||||||||||||
| OrthoDB | EOG4F4S9M. | ||||||||||||||||||
| PhylomeDB | Q13586. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Pathway_Interaction_DB | tcrpathway. TCR signaling in naive CD4+ T cells. cd8tcrpathway. TCR signaling in naive CD8+ T cells. | ||||||||||||||||||
| Reactome | REACT_604. Hemostasis. REACT_6900. Immune System. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q13586. | ||||||||||||||||||
| Bgee | Q13586. | ||||||||||||||||||
| CleanEx | HS_STIM1. | ||||||||||||||||||
| Genevestigator | Q13586. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| Gene3D | 1.10.150.50. 1 hit. | ||||||||||||||||||
| InterPro | IPR001660. SAM. IPR013761. SAM/pointed. IPR011510. SAM_2. [Graphical view] | ||||||||||||||||||
| Pfam | PF07647. SAM_2. 1 hit. [Graphical view] | ||||||||||||||||||
| SMART | SM00454. SAM. 1 hit. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF47769. SAM_homology. 1 hit. | ||||||||||||||||||
| PROSITE | PS00018. EF_HAND_1. False negative. PS50222. EF_HAND_2. False negative. PS50105. SAM_DOMAIN. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| ChiTaRS | STIM1. human. | ||||||||||||||||||
| EvolutionaryTrace | Q13586. | ||||||||||||||||||
| GenomeRNAi | 6786. | ||||||||||||||||||
| NextBio | 26496. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | STIM1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q13586 Secondary accession number(s): Q8N382 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
